One of the world’s most lucrative industries, spending on cancer drugs reached an all-time high last year, as it was valued at more than $100 billion. Spending on cancer drugs increased 6.5 percent annually over the past five years and is expected to continue growing at a rate of 8 percent each year through 2018, according to figures provided by the IMS Institute for Healthcare Informatics.
The post REVEALED: Cancer Industry Profits ‘Locked In’ By Nagalase Molecule Injected Via VACCINES… Spurs Tumor Growth… Explains Aggressive FORCED Vaccine Push! appeared first on Pakalert Press.